WCN26-3451 WHEN KIDNEYS CAN’T BE BIOPSIED, SKIN BIOPSY IDENTIFIES SLE RELAPSE ON DIALYSIS

Read full text Summarise with VIRAT
Authors: Tetsuro Rikihisa, Yusuke Yoshimura, Yuki Oba, Eiko Hasegawa, Akinari Sekine, Masayuki Yamanouchi, Tetsuya Suwabe, Nobukazu Hayashi, Kei Kono, Kenichi Ohashi, Yutaka Yamaguchi, Takehiko Wada
+2 more Naoki Sawa, Yoshifumi Ubara
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Systemic lupus erythematosus (SLE) is characterized by the deposition of immunoglobulin (Ig)G in tissues, which in turn activates the classical pathway of complements such as C1q, C4, and C3, thus mobilizing inflammatory cells and causing tissue damage. The organs affected by SLE include the kidneys, where deposition of IgG, C1q, and C3 is seen, allowing disease activity to be assessed as lupus nephritis in renal tissue and making kidney biopsy an essential test in SLE. However, once patients have developed end-stage renal failure and require hemodialysis, kidney biopsy is no longer an effective method for assessing SLE activity.

Fields of Study & Subjects

Systemic Lupus Erythematosus Research Vasculitis and related conditions Renal Diseases and Glomerulopathies

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105216–105216
Publication date
25 March 2026
Language
EN